✦ LIBER ✦

A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study

✍ Scribed by Tominaga, Kazunari; Kato, Mototsugu; Takeda, Hiroshi; Shimoyama, Yasuyuki; Umegaki, Eiji; Iwakiri, Ryuichi; Furuta, Kenji; Sakurai, Koichi; Odaka, Takeo; Kusunoki, Hiroaki; Nagahara, Akihito; Iwakiri, Katsuhiko; Furuta, Takahisa; Murakami, Kazunari; Miwa, Hiroto; Kinoshita, Yoshikazu; Haruma, Ken; Takahashi, Shin’ichi; Watanabe, Sumio; Higuchi, Kazuhide; Kusano, Motoyasu; Fujimoto, Kazuma; Arakawa, Tetsuo

Book ID: 121549801
Publisher: Springer Japan
Year: 2014
Tongue: English
Weight: 619 KB
Volume: 49
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-013-0896-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

96 A Randomized, Controlled, Double-Blin

96 A Randomized, Controlled, Double-Blind Clinical Trial of Rikkunshito Versus Placebo for Gastrointestinal Symptoms and Quality of Life in Patients With Proton Pump Inhibitor -Refractory Non-Erosive Reflux Disease: The G-Pride Study

✍ Kato, Mototsugu; Takeda, Hiroshi; Tominaga, Kazunari; Kusunoki, Hiroaki; Furuta, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Clinical characteristics of elderly pati

Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito

✍ Yasuhisa Sakata,Kazunari Tominaga,Mototsugu Kato,Hiroshi Takeda… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 528 KB

A Study on the Efficacy of Rebamipide fo

A Study on the Efficacy of Rebamipide for Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease

✍ Kyoichi Adachi, Kenji Furuta, Hiroto Miwa, Tadayuki Oshima, Masaharu Miki, Yoshi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 224 KB

Randomised clinical trial: efficacy of t

Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease – a double-blind, placebo-controlled study

✍ H. Miwa; K. Inoue; K. Ashida; T. Kogawa; A. Nagahara; S. Yoshida; N. Tano; Y. Ya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Mo1069 Efficacy of Addition of Irsogladi

Mo1069 Efficacy of Addition of Irsogladine Maleate to Rabeprazole in the Treatment of Patients With Non-Erosive Reflux Disease - A Double-Blind, Placebo-Controlled Study

✍ Suzuki, Takayoshi; Matsushima, Masashi; Igarashi, Muneki; Koike, Jun; Mine, Tets 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB